
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>What is an IUD: The Complete Guide to Intrauterine Devices — Her Body Guide</title>
    <meta name="description" content="Comprehensive scientific guide to IUDs covering types, mechanisms, history, costs, effectiveness, and side effects. Evidence-based insights for understanding intrauterine devices.">
    <meta name="keywords" content="IUD, intrauterine device, period, hormone, ivf, matt and abby, unplanned, pregnancy, std, birth control, contraception, copper IUD, hormonal IUD, Mirena, Paragard, reproductive health">
    <link rel="stylesheet" href="styles.css" />
    <script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-2936158828082668"
     crossorigin="anonymous"></script>
</head>
<body>

    
    <button class="mobile-toggle" onclick="toggleSidebar()">☰</button>

    <div id="sidebar" class="sidebar">
      <!-- Sidebar content -->
   
    <ul class="sidebar-nav">
    <li class="nav-section">
      <button class="section-header" onclick="toggleSection(this)">
        Conceiving Confidently <span class="section-toggle">◀</span>
      </button>
         <ul class="section-content">
        <li><a href="post1.html">Factors affecting fertilization</a></li>
        <li><a href="post2.html">Reproductive Anatomy</a></li>
        <li><a href="post3.html">Prenatal Vitamins</a></li>
        <li><a href="miscarriage.html">Miscarriage</a></li>
        <li><a href="hormones.html">Reproductive Hormones</a></li>
        <li><a href="what-is-fertility.html">What is Fertility?</a></li>
        <li><a href="pcos.html">PCOS</a></li>
       <li><a href="ivfegg.html">IVF and Egg Freezing</a></li>
           <li><a href="pregtest.html">Pregnancy Tests</a></li>
             <li><a href="twins.html">Twins</a></li>
            <li><a href="iui.html">IUI</a></li>
      </ul>
    </li>
    
    <li class="nav-section">
      <button class="section-header" onclick="toggleSection(this)">
        Contraception<span class="section-toggle">◀</span>
      </button>   <ul class="section-content">
        <li><a href="birthcontrolpills.html">Birth Control pills</a></li>
        <li><a href="iud.html">IUD</a></li>
        <li><a href="rod.html">Contraceptive implant - The Rod</a></li>
        <li><a href="condoms.html">The Science of Condoms</a></li>
      </ul>
    </li>
    
      <li class="nav-section">
        <button class="section-header" onclick="toggleSection(this)">
          Female anatomy and conditions <span class="section-toggle">◀</span>
        </button>  
        <ul class="section-content">
        <li><a href="post2.html"> Reproductive Anatomy</a></li>
        <li><a href="hormones.html">Reproductive Hormones</a></li>
        <li><a href="pcos.html">PCOS</a></li>
        <li><a href="endometriosis.html">Endometriosis</a></li>
        <li><a href="endobelly.html">Endobelly</a></li>
       <li><a href="cysts.html">Ovarian Cysts</a></li>
          <li><a href="vagina.html">The Vagina</a></li> 
           <li><a href="menopause.html"> Menopause and perimenopause</a></li>
          <li><a href="uterus.html"> The Uterus</a></li>
           <li><a href="breastcancer.html"> Breast Cancer</a></li>
        </ul>
    </li>

      <li class="nav-section">
        <button class="section-header" onclick="toggleSection(this)">
        Menstruation <span class="section-toggle">◀</span>
      </button> 
       <ul class="section-content">
        <li><a href="period.html">Period</a></li>
        <li><a href="birthcontrolpills.html">Birth Control pills</a></li>
        <li><a href="cramps.html">Period Cramps</a></li>
        <li><a href="cluevsflo.html">Clue vs Flo</a></li>
         <li><a href="tampons.html">Tampons</a></li>
      </ul>
    </li>
      <li class="nav-section">
        <button class="section-header" onclick="toggleSection(this)">
          Pregnancy <span class="section-toggle">◀</span>
        </button>  
        <ul class="section-content">
        <li><a href="morning-sickness.html">Morning Sickness</a></li>
        <li><a href="breastfeeding.html">Breastfeeding</a></li>
        <li><a href="ultrasoundlmp.html">Pregnancy Dating</a></li>
        <li><a href="blood.html">The Science of blood</a></li>
        <li><a href="post3.html">Prenatal Vitamins</a></li>
        <li><a href="miscarriage.html">Miscarriage</a></li>
        <li><a href="pregfoods.html">Pregnancy dietary restrictions</a></li>
      <li><a href="laborinduction.html">The Science of Labor Induction Methods</a></li>
        <li><a href="gender.html">Gender predicting & Old wives tales</a></li>
         <li><a href="chempreg.html">Chemical Pregnancy</a></li>
             <li><a href="pregtest.html">Pregnancy Tests</a></li>
             <li><a href="twins.html">Twins</a></li>
           <li><a href="laborinduction.html">Labor Induction</a></li>
           <li><a href="vaccinebaby.html">Infant Vaccinations</a></li>
          <li><a href="homebirths.html">Home Births</a></li>
          <li><a href="pregsym.html"> Pregnancy symptoms</a></li>
          <li><a href="fetalgrowth.html">Fetal Growth</a></li>
      </ul>
    </li>
      <li class="nav-section">
        <button class="section-header" onclick="toggleSection(this)">
         Legal Rights <span class="section-toggle">◀</span>
        </button>  
         <ul class="section-content">
        <li><a href="what-is-consent.html">What is Consent?</a></li>
       </ul>
    </li>
    <!-- Add more sections as needed -->
  </ul> 

    </div>
    <header class="site-header">
        <div class="wrapper">
            <h1 class="site-title"><a href="index.html">Her Body Guide</a></h1>
            <p class="site-tagline">Science-based guidance for women for their bodies</p>
        </div>
        <nav class="main-navigation">
            <ul class="nav-menu">
              <li><a href="index.html">Home</a></li>
              <li><a href="contact-and-privacy-policy.html">Contact & Privacy Policy</a></li>
            </ul>
          </nav>
    </header>
    <div class="category-breadcrumb">
        <div class="breadcrumb-content">
            <div class="category-tags">
                 <span class="category-tag">Contraception</span>
            </div>
            <div class="breadcrumb-nav">
                  <a href="index.html">Home</a> → <a href="index.html#contraception">Contraception</a> 

            </div>
        </div>
    </div>
    <div class="post-meta">
        <span class="post-date">June 5, 2025</span>
    </div>

    <div class="post-image" style="background-image: url('https://via.placeholder.com/1200x500?text=Understanding+IUDs');"></div>

    <div class="container">
        <h1>What is an IUD: The Complete Guide to Intrauterine Devices</h1>
        <div class="intro">
            Intrauterine devices (IUDs) represent one of the most effective forms of reversible contraception available today, with failure rates as low as 0.02-0.08%. Used by over 200 million women worldwide, IUDs offer long-acting birth control that can prevent pregnancy for 3-12 years depending on the type. Despite their high effectiveness and growing popularity, IUDs remain misunderstood by many women and even healthcare providers. This comprehensive guide explores the science, history, types, mechanisms, costs, and considerations surrounding IUDs, providing evidence-based information to help women make informed decisions about this contraceptive option.
        </div>

        <h2>Defining the IUD: What Is an Intrauterine Device?</h2>

        <div class="anatomy-section">
            <h3>The Basic Structure</h3>
            <p>An intrauterine device (IUD) is a small, T-shaped contraceptive device made primarily of flexible plastic that is inserted into the uterus by a healthcare provider. <span class="highlight">All modern IUDs share the characteristic T-shape, which allows the horizontal arms to extend across the fundus (top) of the uterus while the vertical stem extends toward the cervix</span>. This design helps keep the device in proper position and reduces the risk of expulsion.</p>
        </div>

        <div class="key-point">
            IUDs are classified as Long-Acting Reversible Contraception (LARC) because they provide continuous birth control for multiple years while allowing for immediate return to fertility upon removal. Currently, 10.4% of U.S. women aged 15-49 use LARC methods, with IUDs comprising the majority of this usage.
        </div>

        <h3>Types of IUDs: Two Distinct Categories</h3>
        <p>Modern IUDs fall into two main categories based on their mechanism of action: copper-releasing and hormone-releasing devices. Each type prevents pregnancy through different biological mechanisms while sharing the same T-shaped design.</p>

        <div class="anatomy-section">
            <h4>Copper IUDs (Non-Hormonal)</h4>
            <p>Copper IUDs consist of a plastic frame wrapped with copper wire. The only copper IUD available in the United States is Paragard, which provides contraceptive protection for up to 12 years. The copper wire releases copper ions into the uterine environment, creating conditions that are toxic to sperm and embryos.</p>
        </div>

        <div class="anatomy-section">
            <h4>Hormonal IUDs (Levonorgestrel-Releasing)</h4>
            <p>Four hormonal IUDs are currently FDA-approved in the United States: Mirena (8 years), Liletta (8 years), Kyleena (5 years), and Skyla (3 years). These devices release the synthetic progestin hormone levonorgestrel directly into the uterine cavity, providing both contraceptive and potential therapeutic benefits.</p>
        </div>

        <h2>The Controversial History of IUDs</h2>

        <h3>Early Development and Ancient Origins</h3>
        <p>The concept of intrauterine contraception has ancient roots, with historical accounts suggesting that Arab and Turkish merchants inserted small stones into camels' uteri to prevent pregnancy during long desert journeys. However, documented human use didn't begin until the early 20th century.</p>

        <div class="anatomy-section">
            <h4>Dr. Richard Richter and the First Modern IUD (1909)</h4>
            <p>Dr. Richard Richter of Poland is credited with developing the first modern intrauterine contraceptive device in 1909. He fashioned a flexible ring from suture material and used a notched instrument for insertion. Despite claiming success in preventing conception, the medical community remained skeptical for nearly 50 years due to concerns about infections and general resistance to contraception.</p>
        </div>

        <h3>The Golden Age: 1960s-1970s Development</h3>
        <p>The 1960s marked a renaissance in IUD development, driven partly by global population control efforts and the recognition that oral contraceptives carried certain health risks.</p>

        <div class="statistic">
            In 1962, Dr. Jack Lippes developed the "Lippes Loop," a simple plastic device shaped like a double S that became the world's most popular IUD. The Loop was inexpensive, easy to insert and remove, and featured a nylon string for detection and removal - innovations that influenced all subsequent IUD designs.
        </div>

        <div class="anatomy-section">
            <h4>The Copper Revolution</h4>
            <p>Chilean physician Dr. Jaime Zipper discovered in the late 1960s that adding copper to IUDs significantly increased their contraceptive effectiveness. This led to the development of copper-bearing devices, with Dr. Howard Tatum creating the first T-shaped copper IUD in 1969. The combination of the T-shape and copper proved to be highly effective and well-tolerated.</p>
        </div>

        <h3>The Dalkon Shield Disaster (1970-1974)</h3>
        <p>The history of IUDs in America was forever changed by the Dalkon Shield, a contraceptive device that became one of the worst medical device disasters in U.S. history.</p>

        <div class="anatomy-section">
            <h4>Development and Marketing</h4>
            <p>Invented by Dr. Hugh Davis and engineer Irwin Lerner in 1968, the Dalkon Shield differed from other IUDs with its crab-like shape featuring fins designed to prevent expulsion. A.H. Robins Company purchased the device in 1970 and launched an aggressive marketing campaign claiming superior safety and effectiveness compared to other birth control methods.</p>
        </div>

        <div class="key-point">
            Between 1970 and 1974, over 2.2 million American women and 4.5 million women worldwide used the Dalkon Shield. However, the device's multifilament tail string allowed bacteria to wick from the vagina into the sterile uterine cavity, leading to severe pelvic infections, septic abortions, infertility, and at least 17 deaths.
        </div>

        <div class="anatomy-section">
            <h4>The Aftermath and Legal Consequences</h4>
            <p>By 1974, mounting evidence of the Dalkon Shield's dangers led the FDA to request its removal from the market. Over 300,000 lawsuits were filed against A.H. Robins, ultimately forcing the company into bankruptcy in 1985. A $2.3 billion trust fund was established to compensate victims, but the damage to IUD reputation lasted decades.</p>
        </div>

        <h3>Recovery and Modern Renaissance</h3>
        <p>The Dalkon Shield disaster devastated IUD acceptance in the United States, with usage dropping to less than 1% by the 1980s. Most manufacturers withdrew their IUDs from the American market due to liability concerns.</p>

        <div class="statistic">
            It took over 15 years for IUDs to recover in the U.S. market. The modern copper IUD (Paragard) received FDA approval in 1984, followed by the first hormonal IUD (Mirena) in 2000. Today, IUD usage has rebounded, with 14% of American women using contraception choosing an IUD as of 2015-2017.
        </div>

        <h2>The Biology and Mechanisms of IUD Action</h2>

        <h3>Copper IUD Mechanisms: Chemical Contraception</h3>
        <p>Copper IUDs prevent pregnancy through multiple interconnected mechanisms, all stemming from the release of copper ions into the uterine environment.</p>

        <div class="anatomy-section">
            <h4>Primary Mechanism: Spermicidal Action</h4>
            <p>Copper ions released from the IUD create a toxic environment for sperm within the female reproductive tract. Studies show that copper concentrations in uterine fluid reach levels of 100-1000 times higher than normal, effectively immobilizing and killing sperm before they can reach the fallopian tubes for fertilization.</p>
        </div>

        <div class="anatomy-section">
            <h4>Inflammatory Response and Immune Activation</h4>
            <p>The presence of copper and the physical device triggers a localized inflammatory response in the endometrium. This inflammation increases the number of immune cells (macrophages, neutrophils) in uterine fluid, which further impairs sperm function and viability.</p>
        </div>

        <div class="key-point">
            Contrary to common misconceptions, research demonstrates that copper IUDs primarily work by preventing fertilization rather than preventing implantation. Studies examining fallopian tube contents show that embryo formation occurs at significantly lower rates in IUD users compared to non-users, indicating that fertilization itself is prevented.
        </div>

        <h3>Hormonal IUD Mechanisms: Progestin-Mediated Effects</h3>
        <p>Hormonal IUDs release 20 micrograms of levonorgestrel daily (Mirena), with lower amounts released by other brands. This local hormone delivery creates multiple contraceptive effects.</p>

        <div class="anatomy-section">
            <h4>Cervical Mucus Changes</h4>
            <p>Levonorgestrel thickens cervical mucus, making it difficult for sperm to penetrate and travel through the cervix. However, studies show that 69% of ovulatory cycles in long-term IUD users still have cervical mucus favorable for sperm transport, indicating this isn't the primary mechanism.</p>
        </div>

        <div class="anatomy-section">
            <h4>Endometrial Suppression</h4>
            <p>The most significant effect of hormonal IUDs is profound suppression of endometrial growth. Levonorgestrel causes the uterine lining to become thin and atrophic, creating an environment unsuitable for implantation should fertilization occur.</p>
        </div>

        <div class="anatomy-section">
            <h4>Ovulation Suppression</h4>
            <p>While hormonal IUDs don't completely suppress ovulation like oral contraceptives, they do reduce ovulation rates. Studies show that 45-85% of women continue to ovulate with hormonal IUDs, with rates varying by duration of use and individual factors.</p>
        </div>

        <h2>Effectiveness: The Statistics of IUD Performance</h2>

        <h3>Failure Rates and Real-World Effectiveness</h3>
        <p>IUDs rank among the most effective contraceptive methods available, with failure rates comparable to permanent sterilization procedures.</p>

        <div class="statistic">
            Clinical trials demonstrate that copper IUDs have a failure rate of 0.6-0.8% per year, while hormonal IUDs show even lower rates of 0.1-0.2% per year. Over 10 years of use, the cumulative pregnancy rate for copper IUDs is approximately 2-6%, making them more effective than tubal ligation in long-term studies.
        </div>

        <div class="anatomy-section">
            <h4>Perfect Use vs. Typical Use</h4>
            <p>Unlike user-dependent methods like pills or condoms, IUD effectiveness doesn't vary between "perfect use" and "typical use" because they require no ongoing user action. Once properly inserted, IUDs provide continuous contraceptive protection regardless of user behavior.</p>
        </div>

        <h3>Effectiveness by Brand and Type</h3>
        <p>Different IUD brands show varying effectiveness rates based on their design, copper content, or hormone dosage.</p>

        <ul>
            <li><strong>Paragard (Copper):</strong> 0.8% annual failure rate, 99.2% effective</li>
            <li><strong>Mirena (Hormonal):</strong> 0.2% annual failure rate, 99.8% effective</li>
            <li><strong>Liletta (Hormonal):</strong> 0.2% annual failure rate, 99.8% effective</li>
            <li><strong>Kyleena (Hormonal):</strong> 0.2% annual failure rate, 99.8% effective</li>
            <li><strong>Skyla (Hormonal):</strong> 0.4% annual failure rate, 99.6% effective</li>
        </ul>

        <h3>Factors Affecting IUD Effectiveness</h3>
        <p>While IUDs are highly effective for most women, certain factors can influence their contraceptive reliability.</p>

        <div class="anatomy-section">
            <h4>Age and Fertility</h4>
            <p>IUD effectiveness increases with age, partly due to naturally declining fertility. Women over 40 have even lower failure rates with IUDs compared to younger women, though the devices remain highly effective across all reproductive ages.</p>
        </div>

        <div class="anatomy-section">
            <h4>Time Since Insertion</h4>
            <p>Failure rates vary by time since insertion, with slightly higher rates in the first year due to unrecognized expulsions or malpositioned devices. After the first year, annual failure rates remain consistently low throughout the device's lifespan.</p>
        </div>

        <h2>The Five FDA-Approved IUDs: Detailed Profiles</h2>

        <h3>Paragard: The Copper Standard</h3>
        <p>Paragard is the only non-hormonal IUD available in the United States and offers the longest duration of contraceptive protection.</p>

        <div class="trimester-box">
            <h3>Paragard Specifications</h3>
            <p><span class="highlight">Material:</span> T-shaped polyethylene frame wrapped with 380mm² of copper wire<br>
            <span class="highlight">Duration:</span> FDA-approved for 10 years, effective for up to 12 years<br>
            <span class="highlight">Size:</span> 32mm horizontal arms, 36mm vertical length<br>
            <span class="highlight">Mechanism:</span> Copper ion release creates spermicidal environment</p>
        </div>

        <div class="anatomy-section">
            <h4>Advantages of Paragard</h4>
            <p>Hormone-free option suitable for women who cannot or prefer not to use hormonal contraception, immediate effectiveness upon insertion, can be used as emergency contraception up to 5 days after unprotected intercourse, does not affect natural hormone cycles or ovulation.</p>
        </div>

        <div class="anatomy-section">
            <h4>Disadvantages and Side Effects</h4>
            <p>May increase menstrual bleeding and cramping, especially in the first 3-6 months after insertion. Some women experience longer, heavier periods throughout use. Not suitable for women with copper allergies or Wilson's disease.</p>
        </div>

        <h3>Mirena: The Original Hormonal IUD</h3>
        <p>Mirena was the first hormonal IUD approved in the United States and remains the most widely studied and prescribed hormonal IUD globally.</p>

        <div class="anatomy-section">
            <h4>Mirena Specifications</h4>
            <p><strong>Hormone Content:</strong> 52mg levonorgestrel reservoir<br>
            <strong>Release Rate:</strong> 20 mcg/day initially, declining to 10 mcg/day by year 5<br>
            <strong>Duration:</strong> FDA-approved for 8 years<br>
            <strong>Size:</strong> 32mm x 32mm frame with hormone reservoir in vertical stem</p>
        </div>

        <div class="anatomy-section">
            <h4>Therapeutic Benefits Beyond Contraception</h4>
            <p>Mirena is FDA-approved for treating heavy menstrual bleeding in women who choose IUD contraception. Studies show 71-95% reduction in menstrual blood loss, with 20% of users experiencing amenorrhea (no periods) after one year of use.</p>
        </div>

        <h3>Liletta: The Cost-Effective Alternative</h3>
        <p>Developed specifically to provide affordable IUD access, Liletta offers similar effectiveness to Mirena at a lower cost for healthcare systems.</p>

        <div class="statistic">
            Liletta was developed through a partnership between Actavis and Medicines360, a non-profit pharmaceutical company, specifically to address cost barriers to IUD access. It's available at significant discounts to clinics participating in the federal 340B Drug Pricing Program.
        </div>

        <h3>Kyleena: The Mid-Range Option</h3>
        <p>Kyleena bridges the gap between high-dose and low-dose hormonal IUDs, offering 5 years of protection with moderate hormone levels.</p>

        <div class="anatomy-section">
            <h4>Kyleena Characteristics</h4>
            <p><strong>Hormone Content:</strong> 19.5mg levonorgestrel<br>
            <strong>Release Rate:</strong> 17.5 mcg/day initially, declining over time<br>
            <strong>Duration:</strong> 5 years<br>
            <strong>Size:</strong> Smaller frame than Mirena, making insertion potentially easier</p>
        </div>

        <h3>Skyla: The Lowest-Dose Option</h3>
        <p>Skyla offers the lowest hormone dose and shortest duration among hormonal IUDs, making it an option for women seeking minimal hormonal exposure.</p>

        <div class="anatomy-section">
            <h4>Skyla Profile</h4>
            <p><strong>Hormone Content:</strong> 13.5mg levonorgestrel<br>
            <strong>Duration:</strong> 3 years<br>
            <strong>Target Population:</strong> Originally marketed to nulliparous women (those who haven't given birth)<br>
            <strong>Menstrual Effects:</strong> Less likely to cause amenorrhea compared to higher-dose IUDs</p>
        </div>

        <h2>IUD Insertion and Removal: The Medical Procedures</h2>

        <h3>Pre-Insertion Evaluation and Counseling</h3>
        <p>Proper IUD insertion requires comprehensive evaluation to ensure safety and optimal outcomes for patients.</p>

        <div class="key-point">
            Healthcare providers must confirm negative pregnancy status before IUD insertion using standardized criteria: less than 7 days after menstrual period start, no intercourse since last menstrual period, correct use of reliable contraception, less than 7 days after spontaneous or induced abortion, or within 4 weeks postpartum if exclusively breastfeeding.
        </div>

        <div class="anatomy-section">
            <h4>Medical History and Physical Examination</h4>
            <p>Providers assess contraindications including active pelvic infection, unexplained uterine bleeding, known or suspected pregnancy, cervical or endometrial cancer, and anatomical abnormalities that would distort the uterine cavity. A pelvic examination evaluates uterine size, position, and cervical anatomy.</p>
        </div>

        <h3>The Insertion Procedure</h3>
        <p>IUD insertion is typically performed in an office setting and takes 5-15 minutes to complete.</p>

        <div class="anatomy-section">
            <h4>Step-by-Step Insertion Process</h4>
            <p>After positioning the patient and performing a sterile pelvic examination, the provider cleanses the cervix and may apply a tenaculum for cervical stabilization. A uterine sound measures cavity depth, and the loaded IUD is inserted through the cervical canal to the uterine fundus. The insertion tube is withdrawn, allowing the IUD arms to deploy, and strings are trimmed to appropriate length.</p>
        </div>

        <div class="anatomy-section">
            <h4>Pain Management During Insertion</h4>
            <p>Most women experience moderate cramping during insertion, similar to strong menstrual cramps. Pre-medication with NSAIDs (ibuprofen 600-800mg) taken 30-60 minutes before insertion can help reduce discomfort. Local anesthetic injection into the cervix may be used for women with anticipated difficult insertion.</p>
        </div>

        <h3>Post-Insertion Care and Follow-Up</h3>
        <p>Proper post-insertion care ensures optimal IUD function and helps identify potential complications early.</p>

        <div class="statistic">
            Studies show that routine follow-up visits 3-6 weeks after insertion help detect malpositioned IUDs and provide reassurance to users. However, asymptomatic women with properly positioned IUDs don't require additional follow-up visits beyond routine gynecologic care.
        </div>

        <h2>Costs and Insurance Coverage: Economic Considerations</h2>

        <h3>Upfront Costs and Long-Term Value</h3>
        <p>While IUDs require significant upfront investment, they prove cost-effective over time compared to other contraceptive methods.</p>

        <div class="anatomy-section">
            <h4>Device and Procedure Costs</h4>
            <p>Without insurance, total IUD costs (device + insertion) range from $800-1,800 depending on the type and healthcare provider. Copper IUDs typically cost $400-1,000, while hormonal IUDs range from $800-1,300. These costs include the device, insertion procedure, and initial follow-up visit.</p>
        </div>

        <div class="statistic">
            Economic analyses demonstrate that IUDs become cost-effective compared to oral contraceptives after approximately 1-2 years of use. Over 10 years, IUD users save thousands of dollars compared to those using monthly prescription methods, even accounting for the higher upfront cost.
        </div>

        <h3>Insurance Coverage Under the Affordable Care Act</h3>
        <p>The Affordable Care Act (ACA) dramatically improved IUD accessibility by requiring most insurance plans to cover contraceptives without cost-sharing.</p>

        <div class="key-point">
            Studies show that 64% of privately insured women paid nothing for their IUD after ACA implementation, compared to much higher out-of-pocket costs before 2012. However, grandfathered insurance plans and certain religious exemptions may not provide full coverage, leading to substantial out-of-pocket expenses for some women.
        </div>

        <div class="anatomy-section">
            <h4>Coverage Variations and Challenges</h4>
            <p>While the ACA requires coverage of FDA-approved contraceptives, insurance plans may only cover one brand per category. Some plans require prior authorization or step therapy. Additionally, coverage for insertion and removal procedures may vary, with some plans covering only the device cost but not associated medical services.</p>
        </div>

        <h3>Financial Assistance Programs</h3>
        <p>Multiple programs help women access IUDs regardless of insurance status or income level.</p>

        <div class="anatomy-section">
            <h4>Federal and State Programs</h4>
            <p>Medicaid covers IUDs in all states as part of family planning services, typically with no cost-sharing for eligible women. Title X clinics receive federal funding to provide contraceptive services on a sliding fee scale based on income. Federally Qualified Health Centers (FQHCs) also offer IUD services with income-based pricing.</p>
        </div>

        <div class="anatomy-section">
            <h4>Manufacturer Patient Assistance Programs</h4>
            <p>IUD manufacturers offer patient assistance programs for uninsured or underinsured women. These programs may provide free or reduced-cost devices for qualifying individuals, though eligibility requirements and application processes vary by manufacturer.</p>
        </div>

        <h2>Side Effects and Complications: Understanding the Risks</h2>

        <h3>Common Side Effects: Expected Changes</h3>
        <p>Most IUD side effects are related to normal physiological responses to device insertion and ongoing presence in the uterus.</p>

        <div class="anatomy-section">
            <h4>Copper IUD Side Effects</h4>
            <p>The most common side effects of copper IUDs include increased menstrual bleeding (averaging 20-50% heavier periods), longer periods (extending 1-2 days), and increased menstrual cramping. These effects are most pronounced in the first 3-6 months after insertion and typically improve over time, though some women experience persistent changes.</p>
        </div>

        <div class="anatomy-section">
            <h4>Hormonal IUD Side Effects</h4>
            <p>Hormonal IUDs commonly cause irregular bleeding patterns, especially in the first 3-6 months. Initial side effects may include headaches, breast tenderness, mood changes, and acne. However, many women experience beneficial effects including lighter periods, reduced cramping, and eventual amenorrhea in 20-25% of users.</p>
        </div>

        <h3>Serious Complications: Rare but Important Risks</h3>
        <p>While IUDs are very safe, serious complications can occur and require prompt medical attention.</p>

        <div class="statistic">
            Major complications occur in less than 1% of IUD insertions. Uterine perforation occurs in 1-4 per 1,000 insertions, typically at the time of placement. Pelvic inflammatory disease affects fewer than 1 in 100 users, usually within the first 21 days after insertion and often related to undiagnosed sexually transmitted infections.
        </div>

        <div class="anatomy-section">
            <h4>Expulsion: When IUDs Come Out</h4>
            <p>IUD expulsion occurs in 3-10% of users, most commonly in the first year after insertion. Risk factors include young age, heavy menstrual bleeding, severe cramping, insertion timing, and previous expulsion. Partial expulsion may reduce contraceptive effectiveness, making string checks important for ongoing protection verification.</p>
        </div>

        <div class="anatomy-section">
            <h4>Ectopic Pregnancy Considerations</h4>
            <p>While IUDs dramatically reduce overall pregnancy risk, any pregnancy that occurs with an IUD in place has a higher likelihood of being ectopic. Approximately 25% of pregnancies with hormonal IUDs and 4% with copper IUDs are ectopic, compared to 2% in the general population. However, IUD users have lower absolute rates of ectopic pregnancy than women using no contraception.</p>
        </div>

        <h2>Special Populations and Considerations</h2>

        <h3>IUDs for Adolescents and Nulliparous Women</h3>
        <p>Medical societies now recommend IUDs as first-line contraception for adolescents and women who haven't given birth, reversing previous restrictive recommendations.</p>

        <div class="key-point">
            Studies consistently show that IUDs are safe and effective in nulliparous women, with similar complication rates to women who have given birth. The American College of Obstetricians and Gynecologists and the American Academy of Pediatrics both recommend IUDs for adolescents seeking long-acting contraception.
        </div>

        <div class="anatomy-section">
            <h4>Benefits for Young Women</h4>
            <p>IUDs offer particular advantages for adolescents and young adults, including forgiveness for inconsistent use patterns common in this age group, privacy from parents or partners, and protection against unintended pregnancy during education and career establishment years. Long-term data show no adverse effects on future fertility.</p>
        </div>

        <h3>Postpartum IUD Insertion</h3>
        <p>IUDs can be inserted immediately after childbirth or during the postpartum period, offering convenient contraception when fertility returns.</p>

        <div class="anatomy-section">
            <h4>Timing Options</h4>
            <p>Immediate postplacental insertion (within 10 minutes of placental delivery) provides contraception before hospital discharge but carries slightly higher expulsion rates (10-27%) compared to interval insertion. Insertion at 4-6 weeks postpartum offers lower expulsion rates (2-8%) but requires a separate visit and interim contraception if desired.</p>
        </div>

        <h3>IUDs and Breastfeeding</h3>
        <p>Both copper and hormonal IUDs are safe during breastfeeding and don't negatively affect milk production or infant health.</p>

        <div class="statistic">
            The World Health Organization classifies both copper and hormonal IUDs as Category 1 (no restrictions) for breastfeeding women. Studies show no difference in breastfeeding duration or success rates between IUD users and non-users, and minimal levonorgestrel appears in breast milk with hormonal IUDs.
        </div>

        <h2>Emergency Contraception: IUDs as Morning-After Prevention</h2>

        <h3>The Copper IUD as Emergency Contraception</h3>
        <p>The copper IUD represents the most effective form of emergency contraception available, surpassing oral emergency contraceptive pills in preventing pregnancy after unprotected intercourse.</p>

        <div class="anatomy-section">
            <h4>Effectiveness Timeline</h4>
            <p>When inserted within 120 hours (5 days) of unprotected intercourse, the copper IUD prevents pregnancy in over 99.9% of cases. This effectiveness doesn't decline with time within the 5-day window, unlike oral emergency contraceptives which become less effective as time passes. The device can then remain in place to provide ongoing contraception for up to 12 years.</p>
        </div>

        <div class="key-point">
            Emergency copper IUD insertion is more effective than any oral emergency contraceptive pill, including ulipristal acetate and levonorgestrel. Unlike emergency pills, IUD effectiveness doesn't vary based on body weight, making it the preferred option for women with higher BMI who may have reduced efficacy with oral methods.
        </div>

        <div class="anatomy-section">
            <h4>Mechanism of Emergency Action</h4>
            <p>As emergency contraception, the copper IUD primarily prevents fertilization through its toxic effects on sperm and eggs. If fertilization has already occurred, the inflammatory environment may also prevent implantation. The exact mechanism remains debated, but the overall effect is highly effective pregnancy prevention.</p>
        </div>

        <h3>Hormonal IUDs and Emergency Contraception</h3>
        <p>Unlike copper IUDs, hormonal IUDs are not effective as emergency contraception because they don't immediately create the necessary contraceptive environment.</p>

        <div class="anatomy-section">
            <h4>Time to Effectiveness</h4>
            <p>Hormonal IUDs require 7 days to achieve contraceptive effectiveness when not inserted during the first 7 days of the menstrual cycle. This delay makes them unsuitable for emergency contraception, though they provide excellent ongoing protection once effective.</p>
        </div>

        <h2>Global Perspectives: IUD Use Worldwide</h2>

        <h3>International Usage Patterns</h3>
        <p>IUD usage varies dramatically between countries, reflecting differences in healthcare systems, cultural attitudes, and regulatory environments.</p>

        <div class="statistic">
            While IUDs are used by over 200 million women worldwide, usage rates vary from less than 5% in some African countries to over 40% in China and several European nations. Norway, Finland, and France report some of the highest IUD usage rates among developed countries, while the United States lags behind at approximately 14% usage among contraceptive users.
        </div>

        <div class="anatomy-section">
            <h4>Cultural and Historical Factors</h4>
            <p>Countries that never experienced the Dalkon Shield disaster, particularly in Europe, maintained higher IUD acceptance throughout the 1980s and 1990s. Additionally, nations with government-sponsored family planning programs often promote IUDs due to their cost-effectiveness and long-term nature.</p>
        </div>

        <h3>Developing World Initiatives</h3>
        <p>International health organizations promote IUD access in developing countries as part of comprehensive family planning strategies.</p>

        <div class="anatomy-section">
            <h4>Cost and Training Programs</h4>
            <p>Organizations like the World Health Organization and USAID support IUD programs through provider training, device procurement, and quality assurance initiatives. These programs aim to increase access to long-acting contraception in regions with high unmet need for family planning.</p>
        </div>

        <h2>Contraindications and Medical Considerations</h2>

        <h3>Absolute Contraindications</h3>
        <p>Certain medical conditions preclude IUD use due to increased risk of serious complications.</p>

        <div class="trimester-box">
            <h3>When IUDs Should Not Be Used</h3>
            <p><span class="highlight">For All IUDs:</span> Current pregnancy, active pelvic infection, unexplained abnormal uterine bleeding, cervical or endometrial cancer, severe uterine cavity distortion<br>
            <span class="highlight">Copper IUD Only:</span> Copper allergy, Wilson's disease<br>
            <span class="highlight">Hormonal IUD Only:</span> Acute liver disease, liver tumors, current breast cancer</p>
        </div>

        <h3>Relative Contraindications and Special Considerations</h3>
        <p>Some conditions require careful evaluation and monitoring but don't absolutely preclude IUD use.</p>

        <div class="anatomy-section">
            <h4>Medical Conditions Requiring Caution</h4>
            <p>Conditions such as HIV infection, immunosuppression, bleeding disorders, and certain anatomical abnormalities may require additional counseling and monitoring but don't necessarily contraindicate IUD use. Individual risk-benefit assessment guides decision-making in these cases.</p>
        </div>

        <h2>Future Developments in IUD Technology</h2>

        <h3>Next-Generation Materials and Designs</h3>
        <p>Researchers are developing improved IUD materials and designs to address current limitations and side effects.</p>

        <div class="anatomy-section">
            <h4>Alternative Metals and Alloys</h4>
            <p>Scientists are investigating zinc, iron, and copper alloys as alternatives to pure copper, aiming to maintain contraceptive effectiveness while reducing bleeding and cramping side effects. These materials could provide better biocompatibility and potentially fewer adverse effects.</p>
        </div>

        <div class="anatomy-section">
            <h4>Frameless IUD Technology</h4>
            <p>Frameless IUDs, such as GyneFix available in some countries, consist of copper sleeves threaded onto a suture anchored to the uterine fundus. This design may reduce expulsion rates and side effects compared to traditional T-shaped devices, though long-term safety and effectiveness data are still being collected.</p>
        </div>

        <h3>Novel Drug-Releasing Systems</h3>
        <p>Future IUDs may deliver medications beyond levonorgestrel, offering therapeutic benefits beyond contraception.</p>

        <div class="key-point">
            Researchers are developing IUDs that could release anti-inflammatory medications, antibiotics for infection prevention, or other hormones for treating conditions like endometriosis. These combination devices could provide contraception while simultaneously treating gynecologic conditions.
        </div>

        <h3>Biodegradable and Temporary Systems</h3>
        <p>New biodegradable materials could create IUDs that dissolve after predetermined periods, eliminating the need for removal procedures.</p>

        <div class="anatomy-section">
            <h4>Advantages of Biodegradable Systems</h4>
            <p>Biodegradable IUDs could reduce healthcare costs by eliminating removal procedures, improve access in regions with limited healthcare infrastructure, and provide options for women who want contraception for specific time periods without long-term commitment.</p>
        </div>

        <h2>Addressing Common Myths and Misconceptions</h2>

        <h3>Fertility Concerns and Recovery</h3>
        <p>One of the most persistent myths about IUDs concerns their effects on future fertility and pregnancy outcomes.</p>

        <div class="statistic">
            Large-scale studies consistently show that IUD use does not impair future fertility. Research following over 80,000 women found that 96.4% of copper IUD users and 95.1% of hormonal IUD users who desired pregnancy conceived within 12 months of IUD removal - rates identical to women who had never used IUDs.
        </div>

        <div class="anatomy-section">
            <h4>Return to Fertility Timeline</h4>
            <p>Fertility returns immediately after copper IUD removal, with ovulation typically occurring within days to weeks. Hormonal IUD users may experience a slightly longer return to normal cycles (1-3 months) as hormone levels normalize, but this doesn't affect overall fertility rates.</p>
        </div>

        <h3>Safety in Young and Nulliparous Women</h3>
        <p>Historical restrictions on IUD use in young women and those who haven't given birth have been thoroughly debunked by modern research.</p>

        <div class="anatomy-section">
            <h4>Evidence-Based Recommendations</h4>
            <p>Current evidence shows that complication rates, effectiveness, and satisfaction rates are similar between nulliparous and parous women. The cervical dilation required for insertion is comparable to that occurring during routine gynecologic procedures, and insertion success rates exceed 95% in experienced hands.</p>
        </div>

        <h3>Cancer Risk Concerns</h3>
        <p>Some women worry that IUDs, particularly hormonal ones, might increase cancer risk, but evidence suggests otherwise.</p>

        <div class="key-point">
            Large epidemiological studies show that hormonal IUD use is associated with reduced risk of endometrial cancer, with protection lasting years after removal. Breast cancer risk does not appear to be increased with IUD use, and cervical cancer risk is unchanged. Some studies suggest possible protection against ovarian cancer as well.
        </div>

        <h2>Patient Counseling and Informed Consent</h2>

        <h3>Essential Information for Informed Decision-Making</h3>
        <p>Comprehensive counseling ensures that women can make informed decisions about IUD use based on accurate information about benefits, risks, and alternatives.</p>

        <div class="anatomy-section">
            <h4>Key Counseling Points</h4>
            <p>Healthcare providers should discuss expected changes in menstrual patterns, potential side effects and their management, proper string checking technique, warning signs requiring medical attention, effectiveness compared to other contraceptive methods, and the voluntary nature of IUD use with ability to remove at any time.</p>
        </div>

        <div class="anatomy-section">
            <h4>Addressing Individual Concerns</h4>
            <p>Counseling should be tailored to individual patient concerns, medical history, and reproductive goals. Providers should address specific questions about pain during insertion, effects on sexual activity, interactions with medications, and long-term safety based on current evidence.</p>
        </div>

        <h3>Shared Decision-Making Process</h3>
        <p>IUD selection should involve collaborative discussion between patient and provider, considering medical factors, personal preferences, and individual circumstances.</p>

        <div class="statistic">
            Studies show that women who receive comprehensive counseling about IUD options have higher satisfaction rates and longer continuation of use. Patient-centered counseling that addresses individual concerns and preferences leads to better contraceptive outcomes and reduced discontinuation rates.
        </div>

        <h2>Accessing IUD Services: Practical Considerations</h2>

        <h3>Finding Qualified Providers</h3>
        <p>While most gynecologists and many family medicine providers can insert IUDs, finding experienced providers improves outcomes and patient satisfaction.</p>

        <div class="anatomy-section">
            <h4>Provider Training and Experience</h4>
            <p>IUD insertion requires specific training and practice to achieve proficiency. Providers who perform frequent insertions have lower complication rates and greater patient satisfaction. Women should feel comfortable asking about their provider's experience and training with IUD insertion.</p>
        </div>

        <div class="anatomy-section">
            <h4>Healthcare Settings</h4>
            <p>IUDs can be inserted in various healthcare settings including private gynecology offices, family planning clinics, community health centers, and some urgent care facilities. Planned Parenthood clinics have particular expertise in IUD services and often offer sliding-scale pricing for uninsured patients.</p>
        </div>

        <h3>Contraceptive Deserts and Access Challenges</h3>
        <p>Geographic and economic barriers can limit IUD access for many American women.</p>

        <div class="key-point">
            Over 19 million women of reproductive age live in "contraceptive deserts" - areas lacking reasonable access to health centers offering the full range of contraceptive methods including IUDs. These women face significant barriers to accessing their preferred contraceptive method, often requiring travel, time off work, and additional childcare arrangements.
        </div>

        <div class="anatomy-section">
            <h4>Rural and Underserved Areas</h4>
            <p>Rural areas particularly lack providers trained in IUD insertion, and economic constraints make it difficult for small practices to stock expensive devices without guaranteed reimbursement. Telemedicine and mobile health services are emerging solutions, but physical presence is still required for insertion procedures.</p>
        </div>

        <h2>IUDs in the Context of Reproductive Justice</h2>

        <h3>Historical Context and Ethical Considerations</h3>
        <p>The history of IUDs is intertwined with population control efforts and reproductive coercion, requiring ongoing attention to ethical contraceptive provision.</p>

        <div class="anatomy-section">
            <h4>Past Misuse and Coercion</h4>
            <p>IUDs were historically used in coercive population control programs targeting marginalized communities, including forced sterilization campaigns and eugenics movements. This history underscores the importance of ensuring that modern IUD programs prioritize individual choice and reproductive autonomy.</p>
        </div>

        <div class="anatomy-section">
            <h4>Ensuring Voluntary Use</h4>
            <p>Contemporary IUD programs must emphasize voluntary informed consent, respect for individual reproductive decisions, and provision of comprehensive contraceptive options. Women should never feel pressured to choose long-acting methods, and removal should be readily available upon request.</p>
        </div>

        <h3>Addressing Disparities in Access</h3>
        <p>Efforts to improve IUD access must address racial, economic, and geographic disparities in contraceptive care.</p>

        <div class="statistic">
            Data show significant disparities in IUD use by race, education, and income level. White women and college-educated women are more likely to use IUDs compared to women of color and those with lower education levels, reflecting differences in healthcare access, provider counseling, and potentially historical mistrust of medical institutions.
        </div>

        <h2>Economic Impact and Cost-Effectiveness</h2>

        <h3>Healthcare System Savings</h3>
        <p>Widespread IUD adoption could generate significant savings for healthcare systems and insurance providers through reduced unintended pregnancy rates.</p>

        <div class="anatomy-section">
            <h4>The Contraceptive CHOICE Project</h4>
            <p>The St. Louis-based CHOICE Project provided free contraceptives, including IUDs, to over 9,000 women and demonstrated dramatic reductions in unintended pregnancy, abortion, and teen birth rates. When barriers to LARC access were removed, 75% of participants chose IUDs or implants, and pregnancy rates fell to less than half the national average.</p>
        </div>

        <div class="key-point">
            Economic analyses suggest that every dollar spent on contraceptive services, including IUD provision, saves healthcare systems $7.09 in pregnancy-related and infant care costs. Expanding IUD access could prevent hundreds of thousands of unintended pregnancies annually while reducing overall healthcare expenditures.
        </div>

        <h3>Individual Financial Benefits</h3>
        <p>For individuals, IUDs provide substantial cost savings compared to other contraceptive methods over their lifespan.</p>

        <div class="anatomy-section">
            <h4>Comparative Cost Analysis</h4>
            <p>Over 10 years, total contraceptive costs for IUD users average $1,500-2,500 including insertion and removal, compared to $4,000-6,000 for oral contraceptive users and $8,000-12,000 for condom users. These calculations include method failures and associated pregnancy costs, demonstrating substantial savings with IUD use.</p>
        </div>

        <h2>Supporting Women Through IUD Use</h2>

        <div class="trimester-box">
            <h3>Key Messages for Healthcare Providers</h3>
            <p>Effective IUD care requires comprehensive counseling about benefits and risks, respect for patient autonomy in contraceptive choice, skilled insertion technique, and ongoing support for side effect management. <span class="highlight">Healthcare providers play a crucial role in ensuring that women receive accurate information, personalized counseling, and continuing care that supports their reproductive goals.</span></p>
        </div>

        <p>Understanding IUDs as highly effective, safe, and reversible contraceptive options helps women make informed decisions about their reproductive health. Modern IUDs offer excellent pregnancy prevention with the convenience of long-acting protection, while preserving fertility for future pregnancy plans.</p>

        <div class="key-point">
            The most important factor in IUD success is ensuring that women receive accurate information, individualized counseling, and ongoing support from knowledgeable healthcare providers. When women can access their preferred contraceptive method and receive appropriate care, IUDs provide excellent reproductive health outcomes with high satisfaction rates.
        </div>

        <p>Whether choosing copper or hormonal IUDs, women benefit from comprehensive education about their options, realistic expectations about side effects, and continuing access to healthcare providers who can address concerns and provide ongoing care. The combination of advancing IUD technology and improved provider training continues to enhance outcomes for women seeking effective contraception.</p>

        <h2>Scientific References</h2>
        <div class="statistic">
            1. Sivin I, Mahgoub SE, McCarthy T, et al. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study. *Contraception*. 1990;42(4):361-378.
            <br><br>2. Daniels K, Daugherty J, Jones J, Mosher W. Current contraceptive use and variation by selected characteristics among women aged 15-44: United States, 2011-2013. *National Health Statistics Reports*. 2015;(86):1-14.
            <br><br>3. Ortiz ME, Croxatto HB. Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action. *Contraception*. 2007;75(6 Suppl):S16-30.
            <br><br>4. Mishell DR Jr. Intrauterine devices: mechanisms of action, safety, and efficacy. *Contraception*. 1998;58(3 Suppl):45S-53S.
            <br><br>5. Trussell J. Contraceptive failure in the United States. *Contraception*. 2011;83(5):397-404.
            <br><br>6. Secura GM, Allsworth JE, Madden T, Mullersman JL, Peipert JF. The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception. *American Journal of Obstetrics and Gynecology*. 2010;203(2):115.e1-7.
            <br><br>7. ACOG Committee Opinion No. 713: Immediate Postpartum Long-Acting Reversible Contraception. *Obstetrics & Gynecology*. 2017;129(2):e32-e37.
            <br><br>8. Cleland K, Zhu H, Goldstuck N, Cheng L, Trussell J. The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience. *Human Reproduction*. 2012;27(7):1994-2000.
            <br><br>9. Hubacher D, Lara-Ricalde R, Taylor DJ, Guerra-Infante F, Guzmán-Rodríguez R. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. *New England Journal of Medicine*. 2001;345(8):561-567.
            <br><br>10. Mansour D, Gemzell-Danielsson K, Inki P, Jensen JT. Fertility after discontinuation of contraception: a comprehensive review of the literature. *Contraception*. 2011;84(5):465-477.
            <br><br>11. Heinemann K, Reed S, Moehner S, Do Minh T. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices. *Contraception*. 2015;91(4):280-283.
            <br><br>12. Braaten KP, Benson CB, Maurer R, Goldberg AB. Malpositioned intrauterine contraceptive devices: risk factors, outcomes, and future pregnancies. *Obstetrics & Gynecology*. 2011;118(5):1014-1020.
            <br><br>13. Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, The American College of Obstetricians and Gynecologists. Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices. *Obstetrics & Gynecology*. 2012;120(4):983-988.
            <br><br>14. Jatlaoui TC, Riley HEM, Curtis KM. The safety of intrauterine devices among young women: a systematic review. *Contraception*. 2017;95(1):17-39.
            <br><br>15. Stanwood NL, Garrett JM, Konrad TR. Obstetrician-gynecologists and the intrauterine device: a survey of attitudes and practice. *Obstetrics & Gynecology*. 2002;99(2):275-280.
        </div>
    <div class="comments-section">
        <h3>Comments</h3>
        <ul class="comments-list"></ul>
        <form class="comment-form">
            <input type="text" placeholder="Your name" class="comment-author" required />
            <textarea placeholder="Your comment" class="comment-text" required></textarea>
            <button type="submit">Add Comment</button>
        </form>
    </div>

    <p class="back-link"><a href="index.html">← Back to blog</a></p>

    <footer class="site-footer">
        <div class="wrapper">
            <p>&copy; 2025 Her Body Guide. All rights reserved.</p>
        </div>
    </footer>

    <button id="backToTop" title="Back to top">↑</button>
    <script src="script.js"></script>
</body>
</html>
